STAT

Decline in U.S. life expectancy deserves more local and national attention

A decline in U.S. life expectancy and the country's low standing compared to others represent a clear call to action to study and improve public health.
Source: APStock

Arguably the greatest American advancement of the 20th century was the 30-year increase in U.S. life expectancy at birth, from 47 years in 1900 to 77 years in 2000. Having achieved that, it’s easy now to take it for granted. Some worrisome signs, though, point to the need to focus on life expectancy once again — locally and nationally.

That focus is important because life expectancy at birth, as a summary indicator of age at death and, by proxy, of our health.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readAmerican Government
STAT+: Pharmalittle: We’re Reading About FTC Reviewing Novo-Catalent Deal, Amneal Opioid Settlement, And More
The FTC wants more information on a $16.5 million deal in which Novo Nordisk's parent company would purchase Catalent, a contract drug manufacturer.

Related Books & Audiobooks